Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Alzheimers Dement. 2022 Apr 18;19(2):549–559. doi: 10.1002/alz.12654

TABLE 1.

GEMS participant characteristics overall and by study community presented as n and percent except where indicated (N = 2564)a

Winston-Salem, NC Sacramento, CA Hagerstown, MD Pittsburgh, PA
All N = 579 N = 781 N = 386 N = 818 P-valueb
All-cause dementia 324 (12.6) 65 (11.2) 108 (13.8) 66 (17.1) 85 (10.4) 0.005
AD only 212 (8.3) 48 (8.3) 66 (8.5) 41 (10.6) 57 (7.0) 0.20
VaD/AD mixed 97 (3.8) 17 (2.9) 34 (4.4) 22 (5.7) 24 (2.9) 0.061
Follow-up time, y, mean (SD) 5.7 (1.5) 5.5 (1.5) 5.7 (1.4) 5.7 (1.6) 5.7 (1.5) 0.082
Age at randomization, y, mean (SD) 78.4 (3.2) 78.3 (3.3) 78.5 (3.1) 78.7 (3.4) 78.2 (3.0) 0.036
Male 1,394 (54.4) 302 (52.2) 449 (57.5) 213 (55.2) 430 (52.6) 0.15
Non-White 84 (3.3) 18 (3.1) 42 (5.4) 1 (0.3) 23 (2.8) <0.001
Placebo assignment 1,285 (50.1) 293 (50.6) 392 (50.2) 181 (46.9) 419 (51.2) 0.56
Education <0.001
 High school or less 930 (36.3) 191 (33.0) 244 (31.2) 208 (53.9) 287 (35.1)
 Some college 628 (24.5) 177 (30.6) 202 (25.9) 76 (19.7) 173 (21.1)
 College graduate 425 (16.6) 105 (18.1) 117 (15.0) 42 (10.9) 161 (19.7)
 Postgraduate 581 (22.7) 106 (18.3) 218 (27.9) 60 (15.5) 197 (24.1)
Smoking status 0.060
 Never 1,017 (40.4) 213 (37.4) 288 (38.0) 175 (45.9) 341 (42.2)
 Former 1,391 (55.2) 327 (57.4) 441 (58.2) 188 (49.3) 435 (53.8)
 Current 110 (4.4) 30 (5.3) 29 (3.8) 18 (4.7) 33 (4.1)
Pack-years smoking 0.022
 0 1030 (43.4) 218 (40.0) 294 (41.5) 175 (48.6) 343 (45.0)
 >0 to 24 692 (29.1) 185 (33.9) 213 (30.1) 84 (23.3) 210 (27.6)
 >24 653 (27.5) 142 (26.1) 201 (28.4) 101 (28.1) 209 (27.4)
Percent of life exposed to SHS 0.009
 ≤1.14 615 (24.6) 129 (22.6) 185 (24.4) 110 (29.2) 191 (24.0)
 >1.14 to ≤24.39 616 (24.6) 138 (24.2) 207 (27.3) 81 (21.5) 190 (23.8)
 >24.39 to ≤46.43 637 (25.4) 137 (24.0) 206 (27.1) 81 (21.5) 213 (26.7)
 >46.43 636 (25.4) 167 (29.2) 161 (21.2) 105 (27.9) 203 (25.5)
NDI, mean (SD)
 5 year −0.08 (3.09) −0.55 (3.37) 0.09 (3.05) 1.73 (1.99) −0.77 (2.99) <0.001
 10 year −0.08 (3.05) −0.60 (3.35) 0.11 (3.01) 1.68 (1.99) −0.72 (2.93) <0.001
 15 year −0.08 (3.01) −0.62 (3.32) 0.10 (2.95) 1.63 (2.03) −0.68 (2.90) <0.001
 20 year −0.09 (2.99) −0.61 (3.31) 0.09 (2.89) 1.60 (2.08) −0.68 (2.88) <0.001
Body mass index, kg/m2, mean (SD) 27.2 (4.2) 27.0 (4.3) 27.2 (4.3) 27.5 (4.1) 27.3 (4.3) 0.25
Alcoholic drinks/wk, mean (SD) 3.7 (6.6) 3.3 (6.0) 5.0 (7.6) 2.1 (4.7) 3.5 (6.4) <0.001
Occupation History 0.001
 Professional 1484 (57.9) 357 (61.7) 473 (60.6) 206 (53.4) 448 (54.8)
 Sales or clerical 436 (17.0) 95 (16.4) 128 (16.4) 57 (14.8) 156 (19.1)
 Manual labor 325 (12.7) 50 (8.6) 88 (11.3) 73 (18.9) 114 (13.9)
 Homemaker 263 (10.3) 65 (11.2) 72 (9.2) 44 (11.4) 82 (10.0)
 Other 56 (2.2) 12 (2.1) 20 (2.6) 6 (1.6) 18 (2.2)
APOE ε4 carrier status 472 (22.9) 94 (20.8) 140 (23.0) 81 (25.0) 157 (23.1) 0.58

Abbreviations: AD, Alzheimer’s disease; APOE, apolipoprotein E.; NDI, neighborhood deprivation index; SD, standard deviation; SHS, secondhand smoke; VaD, vascular dementia.

a

Information was missing for the following covariates: APOE ε4 carrier status (n = 500), body mass index (n = 9), alcohol number (n = 38), smoking (n = 46), passive smoking percentage (n = 60), pack-years (n = 189), and NDI (n = 2).

b

Differences by study community were examined using analysis of variance or chi-square tests, as appropriate.